| Test Name: |
|
HLA DQ for Narcolepsy
|
|
|
|
|
|
|
| Test Code(s): |
|
DQNARC/ HCDQNARC
|
|
|
|
|
|
|
| CPT Code(s): |
|
86817
|
|
|
|
|
|
|
| Methodology: |
|
Reverse SSO detected by Luminex xMAP (Multi-Analyte Profiling)
|
|
|
|
|
|
|
| Days Performed: |
|
Mon-Fri, dayshift.
|
|
|
|
|
|
|
| Turnaround Time: |
|
Stat: Not available stat.
Routine: 3 working days.
|
|
|
|
Specimen Requirements
|
|
|
|
| Specimen: |
|
Blood
|
|
|
|
|
|
|
| Patient Preparation: |
|
No transfusions (RBC, WBC, Platelets) within 24 hours prior to collection.
|
|
|
|
|
|
|
| Collection Container: |
|
Preferred: Lavender top
Also Acceptable:
Yellow top(with ACD-A/B anticoagulant)
|
|
|
|
|
|
|
| Collection Volume: |
|
Preferred: 4 mL
Pediatrics: 1 mL
|
|
|
|
|
|
|
| Volume Required: |
|
Preferred: 4 mL
Pediatrics: 1 mL
|
|
|
|
|
|
|
| Specimen Transport: |
|
Transport whole blood specimen at room temperature or refrigerated to UWHC Core Laboratory (B4/220).
|
|
|
|
|
|
|
| Stability: |
|
Ambient: 7 days
Refrigerated: 3 weeks
Frozen: Not acceptable
|
|
|
|
Interpretation
|
|
|
|
|
|
|
A written interpretive report will be provided.
|
|
|
|
|
|
|
| Additional Information: |
|
This test was developed and its performance characteristics determined by this laboratory. It has not been cleared or approved by the US Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing.
|
